SUTRO BIOPHARMA, INC. (STRO) › Total LiabilitiesSUTRO BIOPHARMA, INC. (STRO) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2017: $47.27M2018: $91.60M2019: $58.58M2020: $62.06M2021: $88.84M2022: $189.90M2023: $321.09M2024: $342.61M2025: $306.28M$306.28M2017Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$306.28M-10.6%2024$342.61M+6.7%2023$321.09M+69.1%2022$189.90M+113.7%2021$88.84M+43.2%2020$62.06M+5.9%2019$58.58M-36.0%2018$91.60M+93.8%2017$47.27M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share